US2023127134A1PendingUtilityA1
Methods for cancer treatment
Est. expirySep 20, 2041(~15.2 yrs left)· nominal 20-yr term from priority
A61M 2027/004A61M 27/002A61M 1/70A61M 2202/0405A61M 1/88A61M 5/1414A61M 5/1723A61M 2039/0273A61M 2039/0276A61B 5/418A61B 5/14546A61B 5/4839A61B 5/6852A61B 5/6866
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to novel surgical drains and associated methods and systems. Specifically, the present invention includes a surgical drain with at least two ports. A first port drains lymphatic fluid from a subject for collection and analysis. The second port functions to introduce a therapeutic into the subject.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method for treating cancer, the method comprising
obtaining surgical drain fluid via an implanted drain; evaluating one or more biomarkers in the drain fluid; administering a treatment via the implanted drain based on characteristics of the biomarkers; and obtaining subsequent drain fluid samples to evaluate efficacy of the treatment.
2 . The method of claim 1 , wherein the biomarkers are selected from cfDNA, ctDNA, a protein, pathogenic DNA or RNA, leukocyte DNA, and epigenetic factors.
3 . The method of claim 1 , wherein the treatment is a systemic chemotherapeutic.
4 . The method of claim 1 , wherein the treatment is a local chemotherapeutic.
5 . The method of claim 1 , wherein the treatment is an immunotherapy.
6 . The method of claim 1 , wherein the subsequent drain fluid sample is obtained within one hour of the administering step, one day of the administering step, or one week after the administering step.
7 . The method of claim 1 , wherein the biomarker is an antibody or antibody fragment.Join the waitlist — get patent alerts
Track US2023127134A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.